Tessera Therapeutics
Develops gene writing technology to treat and cure diseases.
biotech
Company facts
Series D+-stage
- Founded
- 2018
- Employees
- 300
- Headquarters
- United States
- Type
- Private
- Funding
- Series D · $200M · 2025
Open positions
1 job
Develops gene writing technology to treat and cure diseases.
Company facts